Kaposi's sarcoma (KS) is a low-grade vascular neoplasm mediated by the human herpesvirus-8. Only 1 clinical subtype, the endemic/African subtype, commonly affects the pediatric population.

The US withdrawal will reveal the underlying truth: African health systems have long been undermined by debt and political neglect.

This approach could enhance diagnostic workflows and improve access to reliable diagnostics in Kaposi sarcoma-endemic regions. Herein, we demonstrate an automated framework by leveraging a MIL-based ...

I developed Kaposi sarcoma in October '92, then disseminated Mycobacterium avium complex and gastrointestinal cytomegalovirus in '93 and '94. Later in '94 I developed pulmonary KS. Dr. Cotton ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Call today to schedule an appointment or fill out an online request form. If requested before 2 p.m. you will receive a response today.

As described last month in the journal CHEST Pulmonary, Dr. Krishna led Sutter's participation in a retrospective, multisite study of a novel technique—indocyanine green-soaked fiducial (ICG-F ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Original Medicare and Part C should provide a comprehensive pulmonary rehabilitation program for a person who has chronic issues with breathing. Original Medicare includes Part A, which is ...

However, there is a forgotten member of this group called Kaposi’s Sarcoma Herpesvirus (KSHV). Its infamy surged years ago because unlike other herpesviruses, KSHV can induce cancer in humans. Despite ...

As sarcoma is rare and heterogeneous, it is difficult to treat. Sarcoma does not discriminate and can affect individuals from young children to the elderly. Different age groups are susceptible to ...